BCR and B-cell chronic lymphocytic leukemia: In agreement with these studies and given our findings, we speculate that constitutive activation of the BCR signal in CLL cells may upregulate SIRT3 and maintain its levels by generating ROS which, on the other hand, promotes cell survival through activation of RTKs like AXL.